Stockman Wealth Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Stockman Wealth Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-3,631	Closed	-$277K	–	208
2023 Q1	$277K	Hold	3,631	–	–	0.06%	165
2022 Q4	$301K	Hold	3,631	–	–	0.07%	148
2022 Q3	$288K	Hold	3,631	–	–	0.08%	140
2022 Q2	$270K	Hold	3,631	–	–	0.07%	156
2022 Q1	$326K	Hold	3,631	–	–	0.07%	151
2021 Q4	$407K	Sell	3,631 -4	-0.1%	-$482	0.08%	137
2021 Q3	$457K	Hold	3,635	–	–	0.1%	121
2021 Q2	$492K	Hold	3,635	–	–	0.12%	112
2021 Q1	$493K	Hold	3,635	–	–	0.14%	106
2020 Q4	$512K	Hold	3,635	–	–	0.16%	96
2020 Q3	$405K	Hold	3,635	–	–	0.15%	98
2020 Q2	$407K	Hold	3,635	–	–	0.15%	104
2020 Q1	$281K	Hold	3,635	–	–	0.12%	108
2019 Q4	$346K	Sell	3,635 -610	-14%	-$52.8K	0.12%	121
2019 Q3	$324K	Sell	4,245 -35	-0.8%	-$2.91K	0.12%	120
2019 Q2	$375K	Hold	4,280	–	–	0.15%	105
2019 Q1	$388K	Sell	4,280 -600	-12%	-$51K	0.17%	100
2018 Q4	$350K	Hold	4,880	–	–	0.17%	99
2018 Q3	$468K	Buy	4,880 +95	+2%	+$9.21K	0.2%	91
2018 Q2	$455K	Buy	4,785 +940	+24%	+$86.4K	0.21%	88
2018 Q1	$337K	Sell	3,845 -115	-3%	-$10.5K	0.15%	106
2017 Q4	$336K	Buy	+3,960	New	+$332K	0.15%	105

Other funds holding XBI

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

APF

Alaska Permanent Fund Juneau, Alaska $1.51B AUM 22.23% 1-Year Est. Return

Stockman Wealth Management's XBI Position: Q2 2023 in Review

Stockman Wealth Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2023, closing a stake of 3,631 shares — an estimated $277K sold.

Stockman Wealth Management first reported a position in XBI in Q4 2017 and held it in 22 quarters. The position peaked at $512K in Q4 2020. 712 funds tracked by Wall St. Rank hold XBI as of Q2 2023.

Stockman Wealth Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2023 after selling out during the quarter.
Stockman Wealth Management sold 3,631 State Street SPDR S&P Biotech ETF shares in Q2 2023, an estimated $277K.
Stockman Wealth Management first reported a position in State Street SPDR S&P Biotech ETF in Q4 2017 and held it in 22 quarters.
Stockman Wealth Management's State Street SPDR S&P Biotech ETF position peaked at $512K in Q4 2020.
712 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2023.

Based on Stockman Wealth Management's 13F filing for Q2 2023, filed 2 Aug 2023.